Search details
1.
A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway.
J Allergy Clin Immunol
; 142(1): 311-314.e6, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29522842
2.
Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy.
Front Immunol
; 15: 1347542, 2024.
Article
in English
| MEDLINE | ID: mdl-38558815
3.
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer.
Eur J Cancer
; 171: 64-74, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35704976
4.
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital.
Cancers (Basel)
; 13(23)2021 Dec 02.
Article
in English
| MEDLINE | ID: mdl-34885194
5.
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
Eur J Cancer
; 150: 190-202, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33932726
6.
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
J Immunother Cancer
; 9(3)2021 03.
Article
in English
| MEDLINE | ID: mdl-33753569
7.
Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.
Front Oncol
; 10: 595804, 2020.
Article
in English
| MEDLINE | ID: mdl-33330085
8.
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
Cancers (Basel)
; 12(7)2020 Jul 08.
Article
in English
| MEDLINE | ID: mdl-32650523
Results
1 -
8
de 8
1
Next >
>>